Johnson & Johnson logo

Johnson & Johnson

UKEX:JNJ (USA)  
₴ 6276.00 (0%) Dec 5
On watch
11.80
P/B:
5.37
Market Cap:
₴ 14.07T ($ 382.50B)
Enterprise V:
₴ 14.31T ($ 388.93B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.79
Equity-to-Asset 0.43
Debt-to-Equity 0.42
Debt-to-EBITDA 1.16
Interest Coverage 29.27
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.78
Distress
Grey
Safe
Beneish M-Score -1.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.21
Quick Ratio 0.96
Cash Ratio 0.53
Days Inventory 124.53
Days Sales Outstanding 54.81
Days Payable 103.13

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate 5.9
3-Year Average Share Buyback Ratio 0.2
Shareholder Yield % 1.52

Financials (Next Earnings Date:2024-01-23)

UKEX:JNJ's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Johnson & Johnson Operating Data

UKEX:JNJ's Complete Operating Data
No operating data available for Johnson & Johnson.

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Johnson & Johnson Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₴) 3,908,139.815
EPS (TTM) (₴) 494.209
Beta 0
Volatility % 1.18
14-Day RSI 0
14-Day ATR (₴) 0
20-Day SMA (₴) 6276
12-1 Month Momentum % 0
52-Week Range (₴) 6276 - 6276
Shares Outstanding (Mil) 2,407.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Johnson & Johnson Filings

Filing Date Document Date Form
No Filing Data

Johnson & Johnson Stock Events

Event Date Price(₴)
No Event Data

Johnson & Johnson Frequently Asked Questions

What is Johnson & Johnson(UKEX:JNJ)'s stock price today?
The current price of UKEX:JNJ is ₴6276.00. The 52 week high of UKEX:JNJ is ₴6276.00 and 52 week low is ₴6276.00.
When is next earnings date of Johnson & Johnson(UKEX:JNJ)?
The next earnings date of Johnson & Johnson(UKEX:JNJ) is 2024-01-23.
Does Johnson & Johnson(UKEX:JNJ) pay dividends? If so, how much?
Johnson & Johnson(UKEX:JNJ) does not pay dividend.

Press Release

Subject Date
No Press Release